Open an account

Strata Skin Sciences

SSKN · NASDAQ

$0.00+$0.0001 (−100.00%)TodayMarket closed ·
No price history for this range.

About SSKN

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 114 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Employees
114
Headquarters
Horsham, Pennsylvania
Listed
Oct 28, 2005
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
strataskinsciences.com

SSKN key statistics

Market cap
6
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.00K
Volume
6
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$2.29
52 Week low
$0.00

Strata Skin Sciences (SSKN) at a glance

Strata Skin Sciences (SSKN) last traded at $0.00, with a market cap of 6 and a price-to-earnings ratio of 0.00.

Volume so far is 6 shares, below the average of 1.00K shares a day.

Over the past year Strata Skin Sciences has ranged from $0.00 to $2.29, and now sits 0% of the way up that range.

Strata Skin Sciences met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q3 FY25 it reported -$0.36 per share against an estimate of -$0.3937.

SSKN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 52.2% on average.

  1. Q4 FY23: reported -$1.10 per share against an estimate of -$0.204
  2. Q1 FY24: reported -$1.00 per share against an estimate of -$0.6579
  3. Q2 FY24: reported -$0.03 per share against an estimate of -$0.714
  4. Q3 FY24: reported -$0.53 per share against an estimate of -$0.4488
  5. Q4 FY24: reported -$1.13 per share against an estimate of -$0.3045
  6. Q1 FY25: reported -$0.58 per share against an estimate of -$0.5263
  7. Q2 FY25: reported -$0.60 per share against an estimate of -$0.2932
  8. Q3 FY25: reported -$0.36 per share against an estimate of -$0.3937

SSKN news

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Avi Kapoor

    Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Avi Kapoor

    Dow Jumps 250 Points; AutoZone Posts Downbeat Earnings

  • Preview: Strata Skin Sciences's Earnings

  • A Peek at Strata Skin Sciences's Future Earnings

  • What to Expect from Strata Skin Sciences's Earnings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.